Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for P3 Health Partners (PIII) over the last 5 years, with Q3 2025 value amounting to $3.3 million.

  • P3 Health Partners' Shares Outstanding (Weighted Average) rose 92.65% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 92.65%. This contributed to the annual value of $145.2 million for FY2024, which is 5299.46% up from last year.
  • Per P3 Health Partners' latest filing, its Shares Outstanding (Weighted Average) stood at $3.3 million for Q3 2025, which was up 92.65% from $3.3 million recorded in Q2 2025.
  • P3 Health Partners' 5-year Shares Outstanding (Weighted Average) high stood at $145.2 million for Q4 2024, and its period low was $2.4 million during Q1 2024.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $43.5 million, with a median of $37.0 million in 2021.
  • As far as peak fluctuations go, P3 Health Partners' Shares Outstanding (Weighted Average) skyrocketed by 17465.31% in 2023, and later tumbled by 9745.75% in 2024.
  • Quarter analysis of 5 years shows P3 Health Partners' Shares Outstanding (Weighted Average) stood at $32.5 million in 2021, then increased by 28.1% to $41.6 million in 2022, then skyrocketed by 128.21% to $94.9 million in 2023, then surged by 52.99% to $145.2 million in 2024, then tumbled by 97.75% to $3.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $3.3 million for Q3 2025, versus $3.3 million for Q2 2025 and $3.3 million for Q1 2025.